Sources | Names Used |
---|---|
CTRPv2 | tanespimycin:bortezomib (250:1 mol/mol) |
PharmacoGx | tanespimycin:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | A4GALT | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | AADAT | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
mRNA | ABAT | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | ABCB1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | ABCB10 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | ABCC2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | ABCC6 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | ABCD3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | ABCE1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
mRNA | ABCF2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |